American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -345 | -330 | -301 | -425 | -750 |
| Depreciation Amortization | 325 | 243 | 159 | 81 | 360 |
| Accounts receivable | -126 | -381 | -322 | -131 | 49 |
| Accounts payable and accrued liabilities | 199 | 252 | 168 | 266 | -246 |
| Other Working Capital | 236 | 252 | 167 | 287 | 342 |
| Other Operating Activity | 160 | 155 | 160 | -144 | 192 |
| Operating Cash Flow | $449 | $191 | $31 | $-66 | $-53 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -173 | -141 | -61 | -2 | -70 |
| Investing Cash Flow | $-173 | $-141 | $-61 | $-2 | $-70 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 9,071 | 27 | 87 | 159 | 232 |
| Debt Issued | N/A | -92 | N/A | N/A | N/A |
| Debt Repayment | -124 | N/A | -72 | -45 | -107 |
| Other Financing Activity | -9,167 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-220 | $-65 | $15 | $114 | $125 |
| Beginning Cash Position | 37 | 37 | 37 | 37 | 35 |
| End Cash Position | 93 | 22 | 22 | 83 | 37 |
| Net Cash Flow | $56 | $-15 | $-15 | $46 | $2 |
| Free Cash Flow | |||||
| Operating Cash Flow | 449 | 191 | 31 | -66 | -53 |
| Capital Expenditure | -173 | -141 | -61 | -2 | -70 |
| Free Cash Flow | 276 | 50 | -30 | -68 | -123 |